Biblio
Export 1354 results:
Author Title [ Type
Filters: First Letter Of Last Name is P [Clear All Filters]
“Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
, “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
, “Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
, “Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.”, J Alzheimers Dis, vol. 64, no. 3, pp. 973-980, 2018.
, “Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.”, J Alzheimers Dis, 2018.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
, “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
, “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
, “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
, “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
, “Quantifying and Examining Reserve in Symptomatic Former National Football League Players.”, J Alzheimers Dis, vol. 85, no. 2, pp. 675-689, 2021.
, “Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
, “Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.”, J Alzheimers Dis, vol. 68, no. 3, pp. 885-923, 2019.
, “Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1269-1277, 2018.
, “Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1419-1428, 2017.
, “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
, “Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.”, J Alzheimers Dis, vol. 50, no. 4, pp. 999-1010, 2016.
, “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
, “Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1767-1780, 2023.
, “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
, “Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.”, J Alzheimers Dis, vol. 50, no. 2, pp. 425-41, 2016.
, “Propagation of tau pathology in a model of early Alzheimer's disease.”, Neuron, vol. 73, no. 4, pp. 685-97, 2012.
, “Propagation of tau pathology in a model of early Alzheimer's disease.”, Neuron, vol. 73, no. 4, pp. 685-97, 2012.
, ,